The Vision

The Vision of Palobiofarma is to discover the first marketed drug based on a selective adenosine receptor modulator.

How do we achieve our vision

Palobiofarma focused internal resources on areas where lies the experience of the management team::

  • Virtual drug design
  • Medicinal Chemistry
  • In Vitro Pharmacology of adenosine
  • Physico-chemical characterization of the compounds
  • Intellectual Property

The remaining activities needed for the full compound characterization and the nomination of a development candidate, such as the pharmacology and toxicology tests, are carried out through partnerships with various companies (CROs), Research Centres and Universities.

Last News